Skip to main content

Abstract

The clinical cardiologist who examines a case of cardiomyopathy (CMP) should systematically consider the possibility of a genetic origin of the disease. After the clinician has excluded other known causes of heart muscle disease (hypertension, ischemia, drugs such as anthracyclines that may damage the myocardium, myocarditis, etc.), the family history has a critical role in the determination of a genetic origin of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Morales A, Cowan J, Dagua J, Hershberger RE (2008) Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail 14:37–45

    Article  PubMed  Google Scholar 

  2. Watkins H, Ashrafian H, McKenna WJ (2008) The genetics of hypertrophic cardiomyopathy: Teare redux. Heart 94:1264–1268. doi:10.1136/hrt.2008.154104

    Article  PubMed  CAS  Google Scholar 

  3. Hershberger RE, Lindenfeld J, Mestroni L et al (2009) Genetic evaluation of cardiomyopathy — a Heart Failure Society of America practice guideline. J Card Fail 15:83–97. doi:10.1016/j.cardfail.2009.01.006

    Article  PubMed  Google Scholar 

  4. Jacoby D, McKenna WJ (2012) Genetics of inherited cardiomyopathy. Eur Heart J 33:296–304. doi: 10.1093/eurheartj/ehr260

    Article  PubMed  CAS  Google Scholar 

  5. Watkins H, McKenna WJ, Thierfelder L et al (1995) Mutations in the genes for cardiac tro-ponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332:1058–1064. doi:10.1056/NEJM199504203321603

    Article  PubMed  CAS  Google Scholar 

  6. Anan R, Shono H, Kisanuki A et al (1998) Patients with familial hypertrophic cardiomyopathy caused by a Phe1 10Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation 98:391–397

    Article  PubMed  CAS  Google Scholar 

  7. Van Driest SL, Ackerman MJ, Ommen SR et al (2002) Prevalence and severity of “benign” mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 106:3085–3090

    Article  PubMed  Google Scholar 

  8. Richard P, Charron P, Carrier L et al (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232. doi:10.1161/01.CIR.0000066323.15244.54

    Article  PubMed  Google Scholar 

  9. Girolami F, Ho CY, Semsarian C et al (2010) Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol 55:1444–1453. doi:10.1016/j.jacc.2009.11.062

    Article  PubMed  CAS  Google Scholar 

  10. Millat G, Bouvagnet P, Chevalier P et al (2010) Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet 53:261–267. doi:10.1016/j.ejmg.2010.07.007

    Article  PubMed  Google Scholar 

  11. Meune C, Van Berlo JH, Anselme F et al (2006) Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 354:209–210. doi:10.1056/NEJMc052632

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luisa Mestroni .

Editor information

Editors and Affiliations

Glossary

Allele:

one of the two copies of a gene. Autosome: non-sex chromosome (22 pairs). Carrier: heterozygous individual.

Dominant:

a trait which is expressed when a single mutant allele is present.

Hemizygosity:

presence of only one allele of the gene, in the sex chromosomes (x and y).

Heterozygosity:

presence of two different alleles of the gene.

Homozygosity:

presence of two identical alleles of the gene.

Lyonization:

inactivation on one of the two X chromosomes in females.

Penetrance:

proportion of individuals who carry a particular gene mutation and also express the phenotype.

Proband:

first affected family member who seeks medical attention for a genetic disorder.

Recessive:

a trait that can be expressed only when both alleles are mutated.

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Moretti, M., Taylor, M.R.G., Merlo, M., Mestroni, L. (2013). Family History. In: Sinagra, G., Mestroni, L., Camerini, F. (eds) Genetic Cardiomyopathies. Springer, Milano. https://doi.org/10.1007/978-88-470-2757-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2757-2_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2756-5

  • Online ISBN: 978-88-470-2757-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics